A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections.

Related Articles

A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections.

Future Microbiol. 2015 Jun 17;:1-14

Authors: Chan C, Hardin TC, Smart JI

Abstract
ABSTRACT  Tissue- and device-associated biofilm infections are important medical problems. These infections are difficult to treat due to a high-level of tolerance to antibiotics. Telavancin has been studied in several in vitro biofilm models and has demonstrated efficacy against staphylococcal and enterococcal-associated biofilm infections, including those formed by methicillin-resistant Staphylococcus aureus. Telavancin was effective against the difficult-to-treat vancomycin- and glycopeptide-intermediate strains of S. aureus in these models. Furthermore, the efficacy of telavancin has been evaluated in several biofilm-related in vivo models, including osteomyelitis, endocarditis and device-associated infections in rabbits. Overall, telavancin exhibited similar or greater efficacy than vancomycin and other comparators in these animal models and maintained activity against vancomycin-intermediate and daptomycin nonsusceptible strains of S. aureus.

PMID: 26083676 [PubMed - as supplied by publisher]